Skip to main content
OpenTrials
Completed

NCT Number: NCT00998387

Validation of the Korean Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)

The purpose of this study is to translate and validate the CAM-ICU for use in the Korean ICU setting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Hospital

Seoul, 110-744, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • older than 18 years
  • admitted to medical ICU at Seoul National University Hospital longer than 24 hours

Exclusion criteria

  • comatose or moribund state throughout the study period
  • preexisting neurologic problem

Treatment and study plan

Primary outcomes

  1. Interrater reliability of Korean CAM-ICU

    Time frame: after completion of study

  2. Sensitivity of Korean CAM-ICU for diagnosing ICU delirium

    Time frame: after completion of study

  3. Specificity of Korean CAM-ICU for diagnosing ICU delirium

    Time frame: after completion of study

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

Translation and Validation of the Korean Version of Confusion Assessment Method for the Intensive Care Unit

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Oct 20, 2009
Registry last updated
Oct 20, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.